SCHEMBL23902148

SCHEMBL23902148

N=C(N)c1ccc(/C=C/c2cccc(/C=C/c3ccc(C(=N)N)cc3)c2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 3/20 0.76
PRMT5 O14744 1/20 0.76
ALDH1A1 P00352 1/20 0.76
HPGD P15428 1/20 0.76
CYP2C19 P33261 1/20 0.76
HSD17B10 Q99714 1/20 0.76
PLAU P00749 5/20 0.67
PLG P00747 2/20 0.67
PLAT P00750 2/20 0.67
KLK1 P06870 2/20 0.67
NQO2 P16083 1/20 0.56
KDM1A O60341 1/20 0.47
F10 P00742 3/20 0.47
F2 P00734 2/20 0.47
FURIN P09958 1/20 0.47
CYP19A1 P11511 1/20 0.47
F12 P00748 1/20 0.46
F7 P08709 1/20 0.46
F3 P13726 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428474 0.88 PRMT1 (0.83) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL428473 0.88 PRMT1 (0.83) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL889782 0.87 PRMT1 (1.00) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL208655 0.87 PRMT1 (1.00) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333159 0.86 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Hydrochloric Acid SCHEMBL11333164 0.86 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL3932459 0.85 PRMT1 (0.95) PRMT1PRMT5ALDH1A1HPGDCYP2C19
Stilbamidine SCHEMBL871695 0.83 PRMT1 (0.91) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL27882869 0.82 PLG (0.70) PRMT1PRMT5ALDH1A1HPGDCYP2C19
SCHEMBL2521983 0.82 PRMT1 (0.79) PRMT1PRMT5ALDH1A1HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309641-A1 AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS PAM, AMPD1, AMPD3 PRMT1 1328/4885PRMT5 1908/4885ALDH1A1 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.